About Endothelin receptor type B
Endothelin receptor type B (EDNRB) is a protein
from Homo sapiens identified by UniProt accession
P24530, 442 residues long.
MolForge cross-references it against 0 known binders and
616 disease associations.
Target properties
| Protein name | Endothelin receptor type B |
| UniProt accession | P24530 |
| Gene | EDNRB |
| Organism | Homo sapiens |
| Length | 442 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (9)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (616)
Diseases linked to this target (Open Targets).
- Waardenburg syndrome type 4A · score 0.75
- ABCD syndrome · score 0.71
- pulmonary arterial hypertension · score 0.61
- Hirschsprung disease · score 0.58
- pulmonary hypertension · score 0.58
- hypertension · score 0.57
- systemic scleroderma · score 0.54
- lean body mass · score 0.51
- type 2 diabetes mellitus · score 0.51
- Waardenburg-Shah syndrome · score 0.51
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P24530-F1 | alphafold | PREDICTED | 75.02 | — |
Amino-acid sequence (442 residues)
MQPPPSLCGR ALVALVLACG LSRIWGEERG FPPDRATPLL QTAEIMTPPT KTLWPKGSNA SLARSLAPAE VPKGDRTAGS PPRTISPPPC QGPIEIKETF KYINTVVSCL VFVLGIIGNS TLLRIIYKNK CMRNGPNILI ASLALGDLLH IVIDIPINVY KLLAEDWPFG AEMCKLVPFI QKASVGITVL SLCALSIDRY RAVASWSRIK GIGVPKWTAV EIVLIWVVSV VLAVPEAIGF DIITMDYKGS YLRICLLHPV QKTAFMQFYK TAKDWWLFSF YFCLPLAITA FFYTLMTCEM LRKKSGMQIA LNDHLKQRRE VAKTVFCLVL VFALCWLPLH LSRILKLTLY NQNDPNRCEL LSFLLVLDYI GINMASLNSC INPIALYLVS KRFKNCFKSC LCCWCQSFEE KQSLEEKQSC LKFKANDHGY DNFRSSNKYS SS
Explore Endothelin receptor type B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets